Print Save or Share

User Reviews for Cerezyme

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Filter by:

Learn more about Cerezyme.

Condition	Reviews	Compare	Avg. Ratings
Gaucher Disease	0 reviews	4 medications	Not rated - Be the first
Thrombocytopenia	0 reviews	38 medications	Not rated - Be the first

Reviews for Cerezyme

There are no reviews - Be the first

See also...

Sign In or Register

Forgot password?

Related Cerezyme Information

Availability Prescription only

CSA Schedule Not a controlled drug

Pregnancy Category Risk cannot be ruled out

Approval History Drug history at FDA

FDA Consumer Updates

More FDA Updates...

Related Pages

Drug Class

Lysosomal enzymes

Recently Approved

Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...
Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell ...

Get Updates by Email

Email me about Cerezyme:

Related News and Articles

Four-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Continued Improvement Across All Endpoints 8 February 2012
Feb 8, 2012 - Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today four-year follow-up data from patients enrolled in the phase 2...
Lixte Biotechnology Holdings Compound LB-205 Reported to Have Therapeutic Potential for Gaucher Disease 19 December 2011
An article in the early edition (December 12, 2011) of the Proceedings of the National Academy of Sciences USA , reported that Lixte's investigational drug,...
FDA Extends Taliglucerase Alfa PDUFA Date to May 1, 2012 15 December 2011
Protalix BioTherapeutics, Inc. announced today that it received notification from the U.S. Food and Drug Administration (FDA) that the FDA has extended the...
Protalix BioTherapeutics' Taliglucerase Alfa Phase III Results Published in Blood, the Journal of the American Society of Hematology 13 September 2011
Protalix BioTherapeutics announced this morning the publication of its pivotal Phase 3 data for taliglucerase alfa for Gaucher Disease in Blood, the Journal...
Shire Presents Positive Data from Fabry and Gaucher Disease Studies that Continue to Support Patient Switches to Replagal (agalsidase alfa) and Vpriv (velaglucerase alfa) 31 August 2011
Data Presented at the 2011 Annual Symposium of the Society for the Study of Inborn Errors of Metabolism (SSIEM) NYON, Switzerland, Aug. 31, 2011 /PRNewswire/...

Related Questions & Answers

How many hours can cerezyme be out of the refrigerator?

More Cerezyme questions

Did you find this page helpful? Yes No

Support

About Drugs.com

Your Privacy

Follow us on: Google+ Facebook Twitter

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.

Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.

Copyright © 2000-2012 Drugs.com. All rights reserved.

We comply with the HONcode standard for trustworthy health information.
Verify here

Terms of Use · Privacy Policy

(web1)